Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and aging

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 8, 2012, Pages 1315-1320

  Chapple, Sarah J ^a   Siow, Richard C M ^a   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antioxidant defenses; ER stress; Nrf2 Keap1 pathway; Oxidative stress; Proteasome

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; ANTIOXIDANT; BUTYLCRESOL; GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEASOME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; UBIQUITIN;

AGING; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CELL PROTECTION; DIABETES MELLITUS; DIET; ENDOPLASMIC RETICULUM STRESS; GENE INDUCTION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STROKE;

EID: 84861464050     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.04.021     Document Type: Short Survey

References (54)

1. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. Journal of Biological Chemistry 1999;274:26071-8.
2. Bloom DA, Jaiswal AK. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. Journal of Biological Chemistry 2003;278:44675-82. (Pubitemid 37377224)
3. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. Journal of Biological Chemistry 2003;278:703-11. (Pubitemid 36790739)
4. Cheng X, Siow RC, Mann GE. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxidants & Redox Signalling 2011;14:469-87.
5. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Molecular and Cellular Biology 2004;24:8477-86. (Pubitemid 39245070)
6. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone Jr MA. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circulation Research 2007;101:723-33. (Pubitemid 47494103)
7. Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, et al. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovascular Research 2009;83:354-61.
8. Eggler AL, Small E, Hannink M, Mesecar AD. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. The Biochemical Journal 2009;422:171-80.
9. Friguet B, Stadtman ER, Szweda LI. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. Journal of Biological Chemistry 1994;269:21639-43.
10. Furukawa M, Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Molecular and Cellular Biology 2005;25:162-71. (Pubitemid 40039808)
11. Groll M, Huber R. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Biochimica et Biophysica Acta 2004;1695:33-44.
12. Grune T, Catalgol B, Licht A, Ermak G, Pickering AM, Ngo JK, et al. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radical Biology & Medicine 2011;51:1355-64.
13. Han Z, Varadharaj S, Giedt RJ, Zweier JL, Szeto HH, Alevriadou BR. Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells. The Journal of Pharmacology and Experimental Therapeutics 2009;329:94-101.
14. Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ, et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochemical Society Transactions 2000;28:33-41. (Pubitemid 30103209)
15. Hsieh CY, Hsiao HY, Wu WY, Liu CA, Tsai YC, Chao YJ, et al. Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells. Journal of Biomedical Science 2009;16:12.
16. Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. Journal of Biological Chemistry 2002;277:42769-74. (Pubitemid 35285650)
17. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Research 2004;94:609-16. (Pubitemid 38387743)
18. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997;236:313-22. (Pubitemid 27373291)
19. Itoh K, Mimura J, Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxidants & Redox Signalling 2010.
20. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes & Development 1999;13:76-86. (Pubitemid 29045117)
21. 2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. Journal of Biological Chemistry 2006;281:27335-45.
22. Jung T, Catalgol B, Grune T. The proteasomal system. Molecular Aspects of Medicine 2009;30:191-296.
23. Kapeta S, Chondrogianni N, Gonos ES. Nuclear erythroid factor 2 (Nrf2) mediated proteasome activation delays senescence in human fibroblasts. Journal of Biological Chemistry 2010.
24. Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, et al. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Archives of Biochemistry and Biophysics 2005;433:342-50. (Pubitemid 39592789)
25. Kwak MK, Cho JM, Huang B, Shin S, Kensler TW. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radical Biology & Medicine 2007;43:809-17. (Pubitemid 47103310)
26. Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Molecular and Cellular Biology 2003a;23:8786-94. (Pubitemid 37433379)
27. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival. Journal of Biological Chemistry 2003b;278:8135-45. (Pubitemid 36800555)
28. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. American Journal of Respiratory and Critical Care Medicine 2009;180:1196-207.
29. Mann GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Current Opinion in Pharmacology 2009;9:139-45.
30. Mann GE, Rowlands DJ, Li FY, de WP, Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovascular Research 2007.
31. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a tethering mechanism: a two-site interaction model for the Nrf2-Keap1 complex. Journal of Biological Chemistry 2006;281:24756-68. (Pubitemid 44274250)
32. Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. Journal of Biological Chemistry 2003;278:4536-41. (Pubitemid 36800950)
33. Noyan-Ashraf MH, Wu L, Wang R, Juurlink BH. Dietary approaches to positively influence fetal determinants of adult health. FASEB Journal 2006;20:371-3. (Pubitemid 46671175)
34. Ogura T, Tong KI, Mio K, Maruyama Y, Kurokawa H, Sato C, et al. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proceedings of the National Academy of Sciences of the United States of America 2010;107:2842-7.
35. Park JS, Jung JS, Jeong YH, Hyun JW, Le TK, Kim DH, et al. Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression. Journal of Neurochemistry 2011;119:909-19.
36. Pickering AM, Linder RA, Zhang H, Forman HJ, Davies KJ. Nrf2 dependent induction of proteasome and Pa28alphabeta regulator is required for adaptation to oxidative stress. Journal of Biological Chemistry 2012.
37. Queisser MA, Yao D, Geisler S, Hammes HP, Lochnit G, Schleicher ED, et al. Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010;59:670-8.
38. Rowlands DJ, Chapple S, Siow RC, Mann GE. Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: roles for F-actin and GPR30. Hypertension 2011;57:833-40.
39. Sahni SK, Rydkina E, Sahni A. The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase- 2 expression in human vascular endothelial cells. Thrombosis Research 2008;122:820-5.
40. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, et al. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. Journal of Biological Chemistry 2002;277:44765-71. (Pubitemid 36159069)
41. Sekhar KR, Soltaninassab SR, Borrelli MJ, Xu ZQ, Meredith MJ, Domann FE, et al. Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for gamma-glutamylcysteine synthetase. Biochemical and Biophysical Research Communications 2000;270:311-7. (Pubitemid 30440433)
42. Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radical Biology & Medicine 2011;51:5-16.
43. Siow RC, Mann GE. Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis. Molecular Aspects of Medicine 2010;31:468-77.
44. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von ZT, et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB Journal 2000;14:1490-8. (Pubitemid 30636554)
45. Stangl K, Stangl V. The ubiquitin-proteasome pathway and endothelial (dys)function. Cardiovascular Research 2010;85:281-90.
46. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2004;101:3381-6. (Pubitemid 38338203)
47. Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Medica 2008;74:1526-39.
48. Takabe W, Warabi E, Noguchi N. Anti-atherogenic effect of laminar shear stress via Nrf2 activation. Antioxidants & Redox Signalling 2011;15:1415-26.
49. Taxis C, Hitt R, Park SH, Deak PM, Kostova Z, Wolf DH. Use of modular substrates demonstrates mechanistic diversity and reveals differences in chaperone requirement of ERAD. Journal of Biological Chemistry 2003;278:35903-13. (Pubitemid 37139908)
50. Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the twosite molecular recognition model. Molecular and Cellular Biology 2006;26:2887-900.
51. Warabi E, Takabe W, Minami T, Inoue K, Itoh K, Yamamoto M, et al. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radical Biology & Medicine 2007;42:260-9. (Pubitemid 44959746)
52. Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH. Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007;116:944-53. (Pubitemid 47300919)
53. Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Molecular and Cellular Biology 2003;23:8137-51. (Pubitemid 37377505)
54. Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D, et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011;60:3055-66.